Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating encouraging results in the management of type 2 diabetes. This synthetic peptide duplicates the actions of naturally occurring GLP-1, a https://keybookmarks.com/story20858185/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes